Headache News and Research

Latest Headache News and Research

One in ten Americans endure pain which lasts for a year or more

According to the latest government statistics 1 in 10 of American adults endure pain which lasts for a year or more.

16 Nov 2006

Study shows Diovan reduced urinary protein excretion in patients with type 2 diabetes and high blood pressure

In patients with high blood pressure and type 2 diabetes, the blood pressure-lowering medication Diovan (valsartan) significantly reduced urinary protein excretion, with high doses providing the greatest sustained reduction , according to data presented at the Amer ican Heart Association's (AHA) Annual Scientific Sessions.

13 Nov 2006

Latest food scare - Salmonella in Hershey chocolate bars

In the latest food scare to hit North America confectionary and biscuits by Hershey Canada have been recalled because they may be tainted with salmonella.

13 Nov 2006

Long-term use of topiramate and kidney-stones

Topiramate (Topamax), a drug commonly prescribed to treat seizures and migraine headaches, can increase the propensity of calcium phosphate kidney stones, researchers at UT Southwestern Medical Center have found.

31 Oct 2006

FDA approves Tyzeka for the treatment of adults with chronic hepatitis B

The Food and Drug Administration (FDA) has approved Tyzeka (telbivudine) for the treatment of adults with chronic hepatitis B (HBV), a serious viral infection that attacks the liver and can cause lifelong infection, scarring of the liver (cirrhosis), and eventually liver cancer, liver failure, and death.

26 Oct 2006

There's good news for kids and teens with migraines

Nearly 40 percent of kids and teens with migraine no longer had headaches 10 years later, and another 20 percent developed less severe headaches, according to a new study published in the October 24, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology.

23 Oct 2006

FDA approves Omnaris, new hay fever drug

The U.S. Food and Drug Administration (FDA) has announced the approval of Omnaris (ciclesonide) nasal spray, a new drug for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis, commonly known as hay fever, in adults and children 12 years of age and older.

23 Oct 2006

Chikungunya adds to Dengue scare in India

The situation in the Indian city of Delhi, which is battling to control an outgreak of dengue fever now approaching epidemic proportions, has been exacerbated by an outbreak of another mosquito bourne disease, Chikungunya.

10 Oct 2006

FDA approves FluLaval

The U.S. Food and Drug Administration (FDA) today approved FluLaval, an influenza vaccine to immunize people 18 years of age and older against the disease caused by strains of influenza virus judged likely to cause seasonal flu in the Northern Hemisphere in 2006-2007.

5 Oct 2006

Rivastigmine improves memory loss for traumatic brain injury patients

Traumatic brain injury patients with moderate to severe memory loss improved their memories while taking the drug rivastigmine, according to a study published in the September 12, 2006, issue of Neurology.

12 Sep 2006

Zolmitriptan nasal spray may be safe and effective in treating painful cluster headaches

Zolmitriptan nasal spray, used to treat migraine headaches, also may be safe and effective in treating painful cluster headaches, according to an article posted online today that will appear in the November 2006 print issue of Archives of Neurology.

12 Sep 2006

New drug sorts out premature ejaculation

According the American Urological Association, premature ejaculation affects about 20% of males in the U.S. aged 18-59.

11 Sep 2006

SSRI's developed for premature ejaculation, safe and effective

A selective serotonin reuptake inhibitor (SSRI) developed specifically for the treatment of premature ejaculation is safe and effective for men severely affected by the condition, according to an Article in this week's issue of The Lancet.

7 Sep 2006

Botox offers an additional tool in preventing the formation of bad scars

Mayo Clinic researchers have found that treating a facial wound in the early healing phase with botulinum toxin (Botox) improves the appearance of a scar later.

8 Aug 2006

Lassa fever reported in Germany

German health authorities have reported to WHO an imported case of Lassa fever, confirmed by laboratory tests at the Bernhard-Nocht-Institute of Tropical Medicine, Hamburg, Germany.

25 Jul 2006

FDA approves Elaprase (idursulfase) for Hunter syndrome

The U.S. Food and Drug Administration (FDA) has approved Elaprase (idursulfase), the first product for the treatment of Hunter syndrome (Mucopolysaccharidosis II, or MPS II).

25 Jul 2006

Matchstick-sized contraceptive implant that lasts for three years

The Food and Drug Administration in the U.S. has given approval for a new contraceptive which will protect women from pregnancy for as long as three years.

20 Jul 2006

Drugs given to stop nausea and vomiting after surgery help only a few people

Between 10 - 28% of people benefit from taking an anti-emetic drug to prevent nausea or vomiting after surgery - this means that if everyone was given the drug the majority of patients would be exposed to the risk of side-effects without gaining any benefit.

19 Jul 2006

Neuraminidase inhibitors for preventing and treating influenza in healthy adults

A class of drugs commonly used to treat typical influenza symptoms such as fever, headache and cough do not prevent people from becoming infected with the flu virus.

19 Jul 2006

Conjugate vaccines for preventing meningococcal C meningitis and septicaemia

A new systematic review suggests that a certain kind of vaccine may help to protect babies and small children from a devastating killer: meningococcal meningitis.

19 Jul 2006